Evidence map›Paper›PMID 34854396›Full record

ArticleJournal of musculoskeletal & neuronal interactions2021

MiR-125a-3p inhibits cell proliferation and inflammation responses in fibroblast-like synovial cells in rheumatoid arthritis by mediating the Wnt/β-catenin and NF-κB pathways via targeting MAST3.

Yingxue Wang, Zhe Yin, Ni Zhang, Huishu Song, Qiuting Zhang, Xuexi Hao, Zhilun Wang

Open access · greenAbstract read
In one paragraph

Article in Journal of musculoskeletal & neuronal interactions, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Differential Spleen miRNA Expression Profile of Beagle Dogs Infected withAnimals : an open access journal from MDPI · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yingxue WangDepartment of Rheumatology, The Second Hospital of Shandong University, Shandong Province, China.
Zhe YinDepartment of Rheumatology, The Second Hospital of Shandong University, Shandong Province, China.
Ni ZhangDepartment of Rheumatology, The Second Hospital of Shandong University, Shandong Province, China.
Huishu SongDepartment of Rheumatology, The Second Hospital of Shandong University, Shandong Province, China.
Qiuting ZhangDepartment of Rheumatology, The Second Hospital of Shandong University, Shandong Province, China.
Xuexi HaoDepartment of Rheumatology, The Second Hospital of Shandong University, Shandong Province, China.
Zhilun WangDepartment of Rheumatology, The Second Hospital of Shandong University, Shandong Province, China.
Second Hospital of Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo explore the role and mechanism of miR-125a-3p in rheumatoid arthritis (RA) progression.

methodsThe RA-tissues and fibroblast-like synovial cells in rheumatoid arthritis (RA-FLS) were used in this study. qRT-PCR, western blot and ELISA assay were performed to detect the expression levels of IL-6, IL-β and ΤΝF-α. Dual-luciferase reporter gene assay was used to observe the binding effect of miR-125a-3p and MAST3, and CCK-8 was used to observe the effect of miR-125a-3p on the proliferation of RA-FLS.

resultsmiR-125a-3p was significantly downregulated in the RA-tissues and RA-FLS, and miR-125a-3p could inhibit the proliferation and reduce the inflammation response of RA-FLS. Besides, MAST3 was found as a target of miR-125a-3p, and increased MAST3 could reverse the effects of miR-125a-3p on RA-FLS including decreased proliferation, reduced inflammation level and the inactivation of Wnt/β-catenin and NF-κB pathways.

conclusionsThis study suggests that miR-125a-3p could inactivate the Wnt/β-catenin and NF-κB pathways to reduce the proliferation and inflammation response of RA-FLS via targeting MAST3.

Indexed as

Arthritis, RheumatoidMicroRNAsMicrotubule-Associated ProteinsProtein Serine-Threonine KinasesCell ProliferationCells, CulturedFibroblastsHumansInflammationNF-kappa BWnt Signaling PathwayMAST3 protein, humanMicroRNAsMicrotubule-Associated ProteinsMIRN125 microRNA, humanNF-kappa BProtein Serine-Threonine KinasesMAST3miR-125a-3pNF-κBRheumatoid ArthritisWnt/β-catenin

Identifiers

PMID34854396
PMCPMC8672414
OpenAlexW3217323864

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.